RBCK1 has been reported to be overexpressed in lung adenocarcinoma [23], breast cancer [24], colorectal cancer [25], and renal cell carcinoma [26, 27], where high RBCK1 expression correlates with an unfavorable prognosis. This evidence concerns the gene RBCK1 and lung adenocarcinoma.